NYSE · EYEG
Financial Services · Asset Management
$33.66
Up+$0.02 (+0.06%)
Updated Sep 26, 2026, 9:18 PM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
EYEG closed at $33.66 after 20 trading sessions, down 2.71% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $33.65 | $33.67 | $33.65 | $33.6589 | 265.5 |
| Sep 24, 2026 | $33.79 | $33.79 | $33.6401 | $33.6401 | 316.53 |
| Sep 23, 2026 | $34.0799 | $34.0799 | $33.8205 | $33.8205 | 951.53 |
| Sep 22, 2026 | $34.15 | $34.15 | $34.15 | $34.15 | 39.09 |
| Sep 21, 2026 | $34.145 | $34.145 | $34.145 | $34.145 | 105.5 |
| Sep 18, 2026 | $34.075 | $34.075 | $34.075 | $34.075 | 41.29 |
| Sep 17, 2026 | $34.13 | $34.1843 | $34.1299 | $34.1843 | 746.29 |
| Sep 16, 2026 | $34.085 | $34.09 | $34.0045 | $34.0045 | 586.31 |
| Sep 15, 2026 | $33.9707 | $33.9707 | $33.9707 | $33.9707 | 41.29 |
| Sep 14, 2026 | $34.03 | $34.03 | $33.985 | $33.985 | 123.29 |
| Sep 11, 2026 | $33.9853 | $33.9853 | $33.9853 | $33.9853 | 19.85 |
| Sep 10, 2026 | $34.0091 | $34.0091 | $34.0091 | $34.0091 | 13.85 |
| Sep 9, 2026 | $34.37 | $34.37 | $34.26 | $34.264 | 2.64K |
| Sep 8, 2026 | $34.38 | $34.38 | $34.38 | $34.38 | 22.89 |
| Sep 4, 2026 | $34.3764 | $34.3764 | $34.3764 | $34.3764 | 23.85 |
| Sep 3, 2026 | $34.41 | $34.41 | $34.35 | $34.3772 | 1.65K |
| Sep 2, 2026 | $34.3391 | $34.3391 | $34.3391 | $34.3391 | 14.85 |
| Sep 1, 2026 | $34.305 | $34.305 | $34.305 | $34.305 | 27.85 |
| Aug 31, 2026 | $34.56 | $34.585 | $34.56 | $34.5611 | 1.82K |
| Aug 28, 2026 | $34.598 | $34.598 | $34.598 | $34.598 | 36.85 |
The latest Smart Investors Daily articles mentioning EYEG.
EYEG research
Company profile and research snapshot.
The fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers may include corporate or other business entities in which a sovereign or governmental agency or entity may have, indirectly or directly, an interest, including a majority or greater ownership interest.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 16, 2021 | HC Wainwright & Co. | Buy | — |
| Nov 12, 2020 | HC Wainwright & Co. | Buy | — |
| Jul 21, 2020 | Alliance Global Partners | Buy | — |
| May 19, 2020 | HC Wainwright & Co. | Buy | — |
| Nov 15, 2017 | H.C. Wainwright | Buy | — |
No generated briefing is available yet.
Benzinga · Oct 1, 2024
This article provides a beginner's guide to investing in different types of bonds, including municipal, corporate, government, and foreign bonds. It discusses factors to consider when choosing bonds, such as risk tolerance, investment goals, and tax implications. The article also outlines several bond investment strategies for beginners.
PennyStocks · Sep 24, 2021
Investing in penny stocks in 2021? Check these three out for next months watchlist The post Best Penny Stocks to Buy Right Now? 3 to Watch in October appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks · Sep 15, 2021
Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
GlobeNewswire Inc. · Sep 9, 2021
WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical-stage specialty pharmaceutical company developing and commercializing products for treating ophthalmic diseases, today announced that EyeGate’s President and Chief Executive Officer, Brian M. Strem, Ph.D., will provide a corporate update and participate in one-on-one investor meetings at the H.C. Wainwright 23rd Annual Global Investment Conference to be held September 13-15, 2021.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning EYEG.
